EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease

Andrew Siderowf, Laura E.A. Heathers, Kimberly Fabrizio, Maggie McGuire Kuhl, Catherine M. Kopil, Emily Flagg, Bridget A. McMahon, Christopher S. Coffey, Audra Bright, Michelle Totten, Lynell P. Lemon, Erinn Bryan, Neha Prakash, Nicola Pavese, Bastiaan R. Bloem, Roy N. Alcalay, Anat Mirelman, Leonidas Stefanis, Njideka Okubadejo, Eduardo Tolosa, Caroline M. Tanner, Tanya Simuni, Sohini Chowdhury, Thomas F. Tropea, Kenneth Marek, Tatiana Foroud

Annals of Neurology · 2026-10 · 100 (S38)

DOI: 10.1002/ana.78239 ↗
AbstractBibliografische Angaben

Abstract

The Parkinson's Progression Markers Initiative (PPMI) has remained at the vanguard of Parkinson's disease (PD) research through evolving recruitment strategies that mirror advances in PD biology. PPMI was initially focused on untreated, early‐stage PD. Over time, it has expanded to include genetic cohorts, prodromal participants identified via olfactory testing and risk factor questionnaires targeting people with rapid eye movement (REM) sleep behavior disorder (RBD). Most recently, PPMI has focused on the biology underlying PD and sought to recruit individuals defined by neuronal alpha‐synuclein disease (NSD) biomarkers. This evolution from clinical to biological enrollment demonstrates the feasibility of biomarker‐driven cohort design and establishes a scalable model for early detection and prevention research in neurodegenerative disease. ANN NEUROL 2026;100:S17–S25

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →